T
Tatiana N. Pashirova
Researcher at Russian Academy of Sciences
Publications - 75
Citations - 1201
Tatiana N. Pashirova is an academic researcher from Russian Academy of Sciences. The author has contributed to research in topics: Micelle & Octane. The author has an hindex of 17, co-authored 68 publications receiving 822 citations. Previous affiliations of Tatiana N. Pashirova include Kazan Federal University & University of Coimbra.
Papers
More filters
Journal ArticleDOI
Nanoparticle Delivery Systems in the Treatment of Diabetes Complications.
Eliana B. Souto,Eliana B. Souto,Selma B. Souto,Joana R. Campos,Patrícia Severino,Tatiana N. Pashirova,Lucia Ya. Zakharova,Lucia Ya. Zakharova,Amélia M. Silva,Alessandra Durazzo,Massimo Lucarini,Angelo A. Izzo,Antonello Santini +12 more
TL;DR: Different types of nanoparticles are discussed for improved delivery of different oral hypoglycemic agents in comparison to conventional therapies for diabetes mellitus.
Journal ArticleDOI
Cationic Surfactants: Self-Assembly, Structure-Activity Correlation and Their Biological Applications.
Lucia Ya. Zakharova,Tatiana N. Pashirova,Slavomira Doktorovova,Ana R. Fernandes,Elena Sánchez-López,Amélia M. Silva,Selma B. Souto,Eliana B. Souto,Eliana B. Souto +8 more
TL;DR: This review focuses on several aspects related to the synthesis of innovative cationic surfactants and their broad biological applications including antimicrobial activity, solubilization of hydrophobic drugs, complexation with DNA, and catalytic effect toward important biochemical reaction.
Journal ArticleDOI
Self-assembly strategy for the design of soft nanocontainers with controlled properties
Lucia Ya. Zakharova,Ruslan R. Kashapov,Tatiana N. Pashirova,Alla B. Mirgorodskaya,Oleg G. Sinyashin +4 more
TL;DR: In this article, an overview of the application of amphiphiles as solubilizing agents and drug and gene delivery systems with structure-activity relationships and stimuli responsibility is presented.
Journal ArticleDOI
Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model.
Tatiana N. Pashirova,Irina V. Zueva,Konstantin A. Petrov,Svetlana S. Lukashenko,Irek R. Nizameev,Natalya V. Kulik,A. D. Voloshina,László Almásy,Marsil K. Kadirov,Patrick Masson,Eliana B. Souto,Lucia Ya. Zakharova,Oleg G. Sinyashin +12 more
TL;DR: In this article, a mixed cationic liposomes based on L-α-phosphatidylcholine and dihexadecylmethylhydroxyethylammonium bromide (DHDHAB) were designed to overcome the BBB crossing by using the intranasal route.
Journal ArticleDOI
New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
Irina V. Zueva,José A. Dias,Sofya V. Lushchekina,Vyacheslav E. Semenov,Marat A. Mukhamedyarov,Tatiana N. Pashirova,Vasiliy M. Babaev,Florian Nachon,Natalia Petrova,L. F. Nurullin,Lucia Ya. Zakharova,Victor I. Ilyin,Patrick Masson,Konstantin A. Petrov +13 more
TL;DR: In transgenic mice, administration of C-35 and donepezil partially reversed synapse loss, decreased the number of amyloid plaques, and restored learning and memory, providing additional evidence that dual binding site inhibitors of AChE have Alzheimer's disease-modifying action.